Science based, Naturally
The company is embedded in the scientific ecosystem of the Maastricht Health Campus. BioActor’s offices are connected to the Maastricht University Medical Centre (MUMC) and the research school NUTRIM, the expert research group on nutrition and health in the Netherlands. This gives us unrivalled access to scientific expertise and clinical facilities. Over the years we have established long-term relationships with top clinicians and scientists at several universities and research institutes.
BioActor’s product development strategy relies on four simple principles:
- Health effects must be Clinically Proven
- New health ingredients must be based on a true Scientific Discovery
- Ingredients must be from a Natural and Renewable source
- All of our products are Premium Quality, produced in Europe
BioActor’s Healthy Living Division is based on the principles of the Mediterranean diet. We work on the development of innovative natural ingredients for use in dietary supplements, medical nutrition, and functional foods. Our ingredients promote healthy living and general well-being. We collaborate with top universities and institutes, which gives us access to scientific expertise and clinical facilities.
BioActor’s Sports Division, Invicta Sports Nutrition Science, develops the next generation of sports nutrition ingredients. We work with an experienced team of sports scientists and the top sports performance centres to test all of our products in scientifically robust studies on athletes and active people. We have ongoing collaborations with TOPSPORT Limburg.
BioActor’s Former Head of Clinical Research MD PhD Bouke Salden defended her dissertation at Maastricht University. The effects of various nutritional interventions on the gastrointestinal and metabolic health of healthy, overweight and obese individuals was...
Come meet us at Vitafoods Europe in Geneva, Switzerland from May 9-11, 2017 at stand H84!
NAXUS®| Results of a randomized controlled trial on reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects published in high impact journal
PRESS RELEASE | NAXUS® Results of a randomized controlled trial on reinforcement of intestinal epithelial barrier by arabinoxylans in overweight and obese subjects published in high impact journal. The Clinical Nutrition Journal has published the results of...